Measurement of PD-1, TIM-3 and LAG-3 protein in non-small cell lung carcinomas (NSCLCs) with acquired resistance to PD-1 axis blockers.

被引：4
|
作者：
Datar, Ila
Mani, Nikita
Henick, Brian S.
Wurtz, Anna
Kaftan, Edward
Herbst, Roy S.
Rimm, David L.
Gettinger, Scott N.
Politi, Katerina A.
Schalper, Kurt Alex
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e14611
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14611
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Subsequent strategies and underlying mechanism of acquired resistance to PD-1 axis inhibitors in advanced non-small cell lung cancer
    Wang, Huilan
    Cheng, Xinyu
    Yang, Fan
    Chen, Lu
    Zhang, Anmei
    Zhong, Liangzhi
    Long, Haixia
    Zhu, Bo
    Wang, Zhongyu
    CHINESE MEDICAL JOURNAL, 2024, 137 (07) : 880 - 882
  • [32] Subsequent strategies and underlying mechanism of acquired resistance to PD-1 axis inhibitors in advanced non-small cell lung cancer
    Wang Huilan
    Cheng Xinyu
    Yang Fan
    Chen Lu
    Zhang Anmei
    Zhong Liangzhi
    Long Haixia
    Zhu Bo
    Wang Zhongyu
    中华医学杂志英文版, 2024, 137 (07)
  • [33] CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer
    Chocarro, L. D. E.
    Blanco, E.
    Fenandez-Rubio, L.
    Garnica, M.
    Zuazo, M.
    Garcia Granda, M. J.
    Bocanegra, A.
    Echaide, M.
    Johnston, C.
    Edwards, C. J.
    Legg, J.
    Pierce, A.
    Arasanz, H.
    Fernandez-Hinojal, G.
    Vera, R.
    Ausin, K.
    Santamaria, E.
    Fernandez-Irigoyen, J.
    Kochan, G.
    Escors, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S216 - S216
  • [34] A bivalent Tim-3/PD-1 bispecific antibody for the treatment of PD-1 antibody resistant or refractory NSCLC.
    Liu, Jiajian
    Luan, Y.
    Deng, H.
    Wang, F.
    Wang, C.
    Zhang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 203 - 203
  • [36] Tim-3 and PD-1: Regulators of adaptive immunity in multiple sclerosis
    Burman, Joachim
    Svensson, Emma
    Fransson, Moa
    Loskog, Angelica
    Mangsbo, Sara
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 141 - 141
  • [37] 恶性实体肿瘤患者外周血T细胞中PD-1、LAG-3、TIM-3的表达情况
    袁园
    陈继中
    朱亦林
    张盛
    韩兴华
    潘跃银
    安徽医科大学学报, 2020, 55 (10) : 1597 - 1605
  • [38] Role of the Tim-3 and PD-1 pathways in T cell exhaustion and antitumor immunity
    Anderson, Ana C.
    CANCER RESEARCH, 2011, 71
  • [39] EXPRESSION AND CORRELATION OF PD-1 AND TIM-3 IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA
    Li, Liping
    Li, Lihong
    Lin, Wu
    ACTA MEDICA MEDITERRANEA, 2021, 37 (02): : 1069 - 1074
  • [40] Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer
    Gettinger, Scott N.
    Wurtz, Anna
    Goldberg, Sarah B.
    Rimm, David
    Schalper, Kurt
    Kaech, Susan
    Kavathas, Paula
    Chiang, Anne
    Lilenbaum, Rogerio
    Zelterman, Daniel
    Politi, Katerina
    Herbst, Roy S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 831 - 839
12345